Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
26
ESLOY Quote, Financials, Valuation and Earnings
Last price:
$133.43
Seasonality move
:
5.11%
Day range:
$138.61 - $141.51
52-week range:
$126.47 - $186.81
Dividend yield:
1.6%
P/E ratio:
50.56x
P/S ratio:
4.05x
P/B ratio:
41.16x
Volume:
84.9K
Avg. volume:
125.5K
1-year change:
-4.21%
Market cap:
$130.8B
Revenue:
$32.2B
EPS (TTM):
$2.79
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ESLOY
EssilorLuxottica SA
|
-- | -- | -- | -- | -- |
|
CLLS
Cellectis SA
|
$12.7M | -$0.11 | 24.25% | -56.58% | $7.25 |
|
DBVT
DBV Technologies SA
|
$1.3M | -$0.22 | -- | -86.12% | $40.16 |
|
GNFTF
Genfit SA
|
$33.6M | -- | -- | -- | -- |
|
NICXF
Nicox SA
|
-- | -- | -- | -- | -- |
|
TRGNF
Transgene SA
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ESLOY
EssilorLuxottica SA
|
$141.21 | -- | $130.8B | 50.56x | $2.25 | 1.6% | 4.05x |
|
CLLS
Cellectis SA
|
$4.02 | $7.25 | $404.4M | -- | $0.00 | 0% | 5.00x |
|
DBVT
DBV Technologies SA
|
$21.52 | $40.16 | $1.2B | -- | $0.00 | 0% | -- |
|
GNFTF
Genfit SA
|
$9.00 | -- | $450.3M | 49.25x | $0.00 | 0% | 9.90x |
|
NICXF
Nicox SA
|
$0.30 | -- | $24.3M | -- | $0.00 | 0% | 5.89x |
|
TRGNF
Transgene SA
|
$1.00 | -- | $132.3M | -- | $0.00 | 0% | 1,122.44x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ESLOY
EssilorLuxottica SA
|
21.86% | 0.279 | -- | 0.63x |
|
CLLS
Cellectis SA
|
54.27% | 0.329 | 41.7% | 1.35x |
|
DBVT
DBV Technologies SA
|
23.24% | -3.992 | 5.85% | 1.41x |
|
GNFTF
Genfit SA
|
-- | -0.368 | -- | -- |
|
NICXF
Nicox SA
|
54.24% | 0.454 | 91.41% | 1.21x |
|
TRGNF
Transgene SA
|
-- | 0.532 | -- | 1.42x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ESLOY
EssilorLuxottica SA
|
-- | -- | 4.89% | 6.07% | -- | -- |
|
CLLS
Cellectis SA
|
$30M | $5.9M | -15.69% | -31.08% | 16.76% | -$4M |
|
DBVT
DBV Technologies SA
|
-$4.3M | -$36.9M | -211.46% | -280.59% | -- | -$32.5M |
|
GNFTF
Genfit SA
|
-- | -- | -- | -- | -- | -- |
|
NICXF
Nicox SA
|
-- | -- | -24.01% | -43.13% | -- | -- |
|
TRGNF
Transgene SA
|
-- | -- | -182.92% | -182.92% | -- | -- |
EssilorLuxottica SA vs. Competitors
-
Which has Higher Returns ESLOY or CLLS?
Cellectis SA has a net margin of -- compared to EssilorLuxottica SA's net margin of 1.68%. EssilorLuxottica SA's return on equity of 6.07% beat Cellectis SA's return on equity of -31.08%.
Company Gross Margin Earnings Per Share Invested Capital ESLOYEssilorLuxottica SA-- -- $57.4B CLLSCellectis SA85.76% $0.01 $219.7M -
What do Analysts Say About ESLOY or CLLS?
EssilorLuxottica SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Cellectis SA has an analysts' consensus of $7.25 which suggests that it could grow by 80.35%. Given that Cellectis SA has higher upside potential than EssilorLuxottica SA, analysts believe Cellectis SA is more attractive than EssilorLuxottica SA.
Company Buy Ratings Hold Ratings Sell Ratings ESLOYEssilorLuxottica SA0 0 0 CLLSCellectis SA2 2 0 -
Is ESLOY or CLLS More Risky?
EssilorLuxottica SA has a beta of 1.023, which suggesting that the stock is 2.267% more volatile than S&P 500. In comparison Cellectis SA has a beta of 2.833, suggesting its more volatile than the S&P 500 by 183.275%.
-
Which is a Better Dividend Stock ESLOY or CLLS?
EssilorLuxottica SA has a quarterly dividend of $2.25 per share corresponding to a yield of 1.6%. Cellectis SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. EssilorLuxottica SA pays 57.66% of its earnings as a dividend. Cellectis SA pays out -- of its earnings as a dividend. EssilorLuxottica SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ESLOY or CLLS?
EssilorLuxottica SA quarterly revenues are --, which are smaller than Cellectis SA quarterly revenues of $35M. EssilorLuxottica SA's net income of -- is lower than Cellectis SA's net income of $586.4K. Notably, EssilorLuxottica SA's price-to-earnings ratio is 50.56x while Cellectis SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EssilorLuxottica SA is 4.05x versus 5.00x for Cellectis SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESLOYEssilorLuxottica SA4.05x 50.56x -- -- CLLSCellectis SA5.00x -- $35M $586.4K
-
Which has Higher Returns ESLOY or DBVT?
DBV Technologies SA has a net margin of -- compared to EssilorLuxottica SA's net margin of --. EssilorLuxottica SA's return on equity of 6.07% beat DBV Technologies SA's return on equity of -280.59%.
Company Gross Margin Earnings Per Share Invested Capital ESLOYEssilorLuxottica SA-- -- $57.4B DBVTDBV Technologies SA-- -$1.21 $68.9M -
What do Analysts Say About ESLOY or DBVT?
EssilorLuxottica SA has a consensus price target of --, signalling downside risk potential of --. On the other hand DBV Technologies SA has an analysts' consensus of $40.16 which suggests that it could grow by 86.61%. Given that DBV Technologies SA has higher upside potential than EssilorLuxottica SA, analysts believe DBV Technologies SA is more attractive than EssilorLuxottica SA.
Company Buy Ratings Hold Ratings Sell Ratings ESLOYEssilorLuxottica SA0 0 0 DBVTDBV Technologies SA4 0 1 -
Is ESLOY or DBVT More Risky?
EssilorLuxottica SA has a beta of 1.023, which suggesting that the stock is 2.267% more volatile than S&P 500. In comparison DBV Technologies SA has a beta of -0.978, suggesting its less volatile than the S&P 500 by 197.819%.
-
Which is a Better Dividend Stock ESLOY or DBVT?
EssilorLuxottica SA has a quarterly dividend of $2.25 per share corresponding to a yield of 1.6%. DBV Technologies SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. EssilorLuxottica SA pays 57.66% of its earnings as a dividend. DBV Technologies SA pays out -- of its earnings as a dividend. EssilorLuxottica SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ESLOY or DBVT?
EssilorLuxottica SA quarterly revenues are --, which are smaller than DBV Technologies SA quarterly revenues of --. EssilorLuxottica SA's net income of -- is lower than DBV Technologies SA's net income of -$33M. Notably, EssilorLuxottica SA's price-to-earnings ratio is 50.56x while DBV Technologies SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EssilorLuxottica SA is 4.05x versus -- for DBV Technologies SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESLOYEssilorLuxottica SA4.05x 50.56x -- -- DBVTDBV Technologies SA-- -- -- -$33M
-
Which has Higher Returns ESLOY or GNFTF?
Genfit SA has a net margin of -- compared to EssilorLuxottica SA's net margin of --. EssilorLuxottica SA's return on equity of 6.07% beat Genfit SA's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ESLOYEssilorLuxottica SA-- -- $57.4B GNFTFGenfit SA-- -- -- -
What do Analysts Say About ESLOY or GNFTF?
EssilorLuxottica SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Genfit SA has an analysts' consensus of -- which suggests that it could fall by --. Given that EssilorLuxottica SA has higher upside potential than Genfit SA, analysts believe EssilorLuxottica SA is more attractive than Genfit SA.
Company Buy Ratings Hold Ratings Sell Ratings ESLOYEssilorLuxottica SA0 0 0 GNFTFGenfit SA0 0 0 -
Is ESLOY or GNFTF More Risky?
EssilorLuxottica SA has a beta of 1.023, which suggesting that the stock is 2.267% more volatile than S&P 500. In comparison Genfit SA has a beta of 0.130, suggesting its less volatile than the S&P 500 by 86.956%.
-
Which is a Better Dividend Stock ESLOY or GNFTF?
EssilorLuxottica SA has a quarterly dividend of $2.25 per share corresponding to a yield of 1.6%. Genfit SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. EssilorLuxottica SA pays 57.66% of its earnings as a dividend. Genfit SA pays out -- of its earnings as a dividend. EssilorLuxottica SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ESLOY or GNFTF?
EssilorLuxottica SA quarterly revenues are --, which are smaller than Genfit SA quarterly revenues of --. EssilorLuxottica SA's net income of -- is lower than Genfit SA's net income of --. Notably, EssilorLuxottica SA's price-to-earnings ratio is 50.56x while Genfit SA's PE ratio is 49.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EssilorLuxottica SA is 4.05x versus 9.90x for Genfit SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESLOYEssilorLuxottica SA4.05x 50.56x -- -- GNFTFGenfit SA9.90x 49.25x -- --
-
Which has Higher Returns ESLOY or NICXF?
Nicox SA has a net margin of -- compared to EssilorLuxottica SA's net margin of --. EssilorLuxottica SA's return on equity of 6.07% beat Nicox SA's return on equity of -43.13%.
Company Gross Margin Earnings Per Share Invested Capital ESLOYEssilorLuxottica SA-- -- $57.4B NICXFNicox SA-- -- $46.8M -
What do Analysts Say About ESLOY or NICXF?
EssilorLuxottica SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Nicox SA has an analysts' consensus of -- which suggests that it could fall by --. Given that EssilorLuxottica SA has higher upside potential than Nicox SA, analysts believe EssilorLuxottica SA is more attractive than Nicox SA.
Company Buy Ratings Hold Ratings Sell Ratings ESLOYEssilorLuxottica SA0 0 0 NICXFNicox SA0 0 0 -
Is ESLOY or NICXF More Risky?
EssilorLuxottica SA has a beta of 1.023, which suggesting that the stock is 2.267% more volatile than S&P 500. In comparison Nicox SA has a beta of -0.043, suggesting its less volatile than the S&P 500 by 104.266%.
-
Which is a Better Dividend Stock ESLOY or NICXF?
EssilorLuxottica SA has a quarterly dividend of $2.25 per share corresponding to a yield of 1.6%. Nicox SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. EssilorLuxottica SA pays 57.66% of its earnings as a dividend. Nicox SA pays out -- of its earnings as a dividend. EssilorLuxottica SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ESLOY or NICXF?
EssilorLuxottica SA quarterly revenues are --, which are smaller than Nicox SA quarterly revenues of --. EssilorLuxottica SA's net income of -- is lower than Nicox SA's net income of --. Notably, EssilorLuxottica SA's price-to-earnings ratio is 50.56x while Nicox SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EssilorLuxottica SA is 4.05x versus 5.89x for Nicox SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESLOYEssilorLuxottica SA4.05x 50.56x -- -- NICXFNicox SA5.89x -- -- --
-
Which has Higher Returns ESLOY or TRGNF?
Transgene SA has a net margin of -- compared to EssilorLuxottica SA's net margin of --. EssilorLuxottica SA's return on equity of 6.07% beat Transgene SA's return on equity of -182.92%.
Company Gross Margin Earnings Per Share Invested Capital ESLOYEssilorLuxottica SA-- -- $57.4B TRGNFTransgene SA-- -- -$660.3K -
What do Analysts Say About ESLOY or TRGNF?
EssilorLuxottica SA has a consensus price target of --, signalling downside risk potential of --. On the other hand Transgene SA has an analysts' consensus of -- which suggests that it could fall by --. Given that EssilorLuxottica SA has higher upside potential than Transgene SA, analysts believe EssilorLuxottica SA is more attractive than Transgene SA.
Company Buy Ratings Hold Ratings Sell Ratings ESLOYEssilorLuxottica SA0 0 0 TRGNFTransgene SA0 0 0 -
Is ESLOY or TRGNF More Risky?
EssilorLuxottica SA has a beta of 1.023, which suggesting that the stock is 2.267% more volatile than S&P 500. In comparison Transgene SA has a beta of 42.864, suggesting its more volatile than the S&P 500 by 4186.443%.
-
Which is a Better Dividend Stock ESLOY or TRGNF?
EssilorLuxottica SA has a quarterly dividend of $2.25 per share corresponding to a yield of 1.6%. Transgene SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. EssilorLuxottica SA pays 57.66% of its earnings as a dividend. Transgene SA pays out -- of its earnings as a dividend. EssilorLuxottica SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ESLOY or TRGNF?
EssilorLuxottica SA quarterly revenues are --, which are smaller than Transgene SA quarterly revenues of $105.2K. EssilorLuxottica SA's net income of -- is lower than Transgene SA's net income of --. Notably, EssilorLuxottica SA's price-to-earnings ratio is 50.56x while Transgene SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for EssilorLuxottica SA is 4.05x versus 1,122.44x for Transgene SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ESLOYEssilorLuxottica SA4.05x 50.56x -- -- TRGNFTransgene SA1,122.44x -- $105.2K --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.96% over the past day.
Buy
83
GCT alert for Feb 27
GigaCloud Technology, Inc. [GCT] is down 10.47% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 6.68% over the past day.
